Brain Canada is pleased to be partnering with Alzheimer’s Association (ALZ) to launch the Advancing Research on Care and Outcome Measurement 2.0 (ARCOM-2) funding program, an international and collaborative competition aimed at addressing significant gaps in care and outcome measurement and providing an opportunity to advance research so that care providers can ensure that they are implementing evidence-based practices and achieving desired outcomes.
Areas of interest for this program include, but are not limited to, care preferences, behavioral expressions, quality metrics, and systems of care in the area of Alzheimer’s or other dementia. Through this partnership, Brain Canada will co-fund up to five (5) successful Canadian-led teams who meet peer review recommendations. Each award is limited to USD $250,000 over a period of up to two years.
Evidence clearly shows that increasing equity, diversity and inclusion (EDI) in research environments enhances excellence, innovation and creativity. Brain Canada and ALS Canada are committed to excellence through equity and encourage applicants of diverse backgrounds to apply to our funding opportunities.
Deadline for receipt of Letters of Intent: July 13, 2022 at 17:00 ET
Deadline for receipt of Full Applications: September 9, 2022 at 17:00 ET
Click here to view the Request for Application.